Medicover Management

Management Kriterienprüfungen 3/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Fredrik Rågmark

Geschäftsführender

€2.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	39.2%
Amtszeit als Geschäftsführer	27.8yrs
Eigentum des Geschäftsführers	1.0%
Durchschnittliche Amtszeit des Managements	3.4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	15.3yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Fredrik Rågmark im Vergleich zu den Einnahmen von Medicover verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Sep 30 2024	n/a	n/a	€20m
Jun 30 2024	n/a	n/a	€23m
Mar 31 2024	n/a	n/a	€22m
Dec 31 2023	€3m	€1m	€18m
Sep 30 2023	n/a	n/a	€8m
Jun 30 2023	n/a	n/a	€5m
Mar 31 2023	n/a	n/a	€1m
Dec 31 2022	€3m	€1m	€12m
Sep 30 2022	n/a	n/a	€37m
Jun 30 2022	n/a	n/a	€59m
Mar 31 2022	n/a	n/a	€88m
Dec 31 2021	€2m	€952k	€102m
Sep 30 2021	n/a	n/a	€93m
Jun 30 2021	n/a	n/a	€90m
Mar 31 2021	n/a	n/a	€52m
Dec 31 2020	€2m	€670k	€26m
Sep 30 2020	n/a	n/a	€14m
Jun 30 2020	n/a	n/a	€4m
Mar 31 2020	n/a	n/a	€16m
Dec 31 2019	€1m	€900k	€23m
Sep 30 2019	n/a	n/a	€19m
Jun 30 2019	n/a	n/a	€19m
Mar 31 2019	n/a	n/a	€20m
Dec 31 2018	€1m	€807k	€22m
Sep 30 2018	n/a	n/a	€28m
Jun 30 2018	n/a	n/a	€26m
Mar 31 2018	n/a	n/a	€23m
Dec 31 2017	€921k	€810k	€19m

Vergütung im Vergleich zum Markt: FredrikDie Gesamtvergütung ($USD2.85M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt UK ($USD2.07M).

Entschädigung vs. Einkommen: FredrikDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Fredrik Rågmark (61 yo)

27.8yrs

Amtszeit

€2,707,000

Vergütung

Mr. Fredrik Ragmark serves as the Chief Executive Officer of Medicover AB (publ). Mr. Ragmark has been employed with Medicover since 1996. He serves as Managing Director and Board Member of Kalvskär AB.Fr...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Fredrik Rågmark	CEO & Director	no data	€2.71m	1.04% SEK 272.5m
Anand Patel	Chief Financial Officer	less than a year	keine Daten	keine Daten
Jaroslaw Urbanczyk	Chief Information Officer	5.1yrs	keine Daten	0.0052% SEK 1.3m
Hanna Bjellquist	Head of Investor Relations	no data	keine Daten	keine Daten
Jenny Brandt	General Legal Counsel	no data	keine Daten	0.031% SEK 8.1m
Andrew Vallance-Owen	Chief Marketing Officer	no data	keine Daten	keine Daten
Kamila Skorupinski	Group Chief People Officer	less than a year	keine Daten	keine Daten
John Stubbington	Chief Operating Officer of Healthcare Services	8.8yrs	keine Daten	0.53% SEK 138.4m
Staffan Ternstrom	Chief Operating Officer for Diagnostic Services	3.4yrs	keine Daten	0.035% SEK 9.2m

3.4yrs

Durchschnittliche Betriebszugehörigkeit

57.5yo

Durchschnittliches Alter

Erfahrenes Management: 0RPSDas Führungsteam des Unternehmens gilt als erfahren (3.4 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Fredrik Rågmark	CEO & Director	27.8yrs	€2.71m	1.04% SEK 272.5m
Robert Jochnick	Independent Director	17.8yrs	€54.60k	1.21% SEK 317.0m
Fredrik Stenmo	Independent Chairman	19.8yrs	€101.50k	4.41% SEK 1.2b
Margareta Nordenvall	Independent Director	23.8yrs	€66.20k	0.060% SEK 15.7m
Arno Bohn	Independent Director	23.8yrs	€63.05k	0.20% SEK 52.3m
Cecil Michael Flemming	Independent Director	9.8yrs	€78.30k	keine Daten
Anne Berner	Independent Director	2.6yrs	€59.85k	keine Daten
Azita Shariati	Independent Director	2.6yrs	€63.05k	0.0015% SEK 384.5k
Peder Jochnick	Independent Director	12.8yrs	€54.60k	2.59% SEK 676.7m
Sonali Chandmal	Independent Director	7.8yrs	€71.45k	0.017% SEK 4.4m

15.3yrs

Durchschnittliche Betriebszugehörigkeit

60.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 0RPSDie Vorstandsmitglieder sind sehr erfahren ( 15.3 ).

Medicover Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

Insider recently bought kr498k worth of stock

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

General Legal Counsel recently sold kr1.2m worth of stock

Insider recently bought kr1.8m worth of stock

Recent updates

Insider recently bought kr498k worth of stock

Third quarter 2024 earnings released: €0.029 loss per share (vs €0.007 loss in 3Q 2023)

Medicover AB (publ) to Report First Half, 2025 Results on Jul 24, 2025

Medicover AB (publ) Announces Nomination Committee for the AGM 2025

Medicover AB (publ), Annual General Meeting, Apr 25, 2025

Medicover AB (publ) Appoints Anand Patel as Chief Financial Officer, Effective October 1, 2024

Second quarter 2024 earnings released: EPS: €0.042 (vs €0.037 in 2Q 2023)

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

General Legal Counsel recently sold kr1.2m worth of stock

Medicover AB (Publ) Provides Revenue Guidance for Year-End 2025

First quarter 2024 earnings released: EPS: €0.041 (vs €0.01 in 1Q 2023)

Upcoming dividend of €0.12 per share

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: €0.12 (vs €0.079 in FY 2022)

Dividend of €0.12 announced

Insider recently bought kr1.8m worth of stock

Full year 2023 earnings released: EPS: €0.12 (vs €0.081 in FY 2022)

Now 22% undervalued

Medicover AB (publ) Provides Earnings Guidance for the Financial Year 2025

Medicover Appoints Kamila Skorupinski as Chief People Officer as of 1 April 2024

Independent Chairman recently bought kr3.9m worth of stock

Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025

Medicover AB (Publ) Provides Revenue Targets for by Year-End 2025

Third quarter 2023 earnings released

Medicover AB (Publ) Announces Resignation of Joe Ryan as Chief Financial Officer

Independent Director recently bought kr303k worth of stock

Medicover AB (publ) Announces Nomination Committee for the Annual General Meeting 2024

Medicover AB (publ), Annual General Meeting, Apr 26, 2024

Independent Director recently bought kr1.4m worth of stock

Independent Chairman recently bought kr6.3m worth of stock

Second quarter 2023 earnings released: EPS: €0.037 (vs €0.01 in 2Q 2022)

Medicover AB (publ) to Report Q1, 2024 Results on Apr 26, 2024

Insider recently bought kr242k worth of stock

Chief Information Officer recently bought kr321k worth of stock

Upcoming dividend of €0.12 per share at 0.7% yield

Full year 2022 earnings released

Now 24% undervalued

Full year 2022 earnings released

Medicover AB (publ) Proposes Dividend for 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2022 earnings released

Medicover AB (publ) to Report Q2, 2023 Results on Jul 26, 2023

Medicover AB (publ) to Report Fiscal Year 2022 Results on Feb 17, 2023

Medicover AB (publ) (OM:MCOV B) acquired Übag Mvz Meindentist Gbr.

Medicover AB (publ) (OM:MCOV B) completed the acquisition of Laurus Medical SRL.

Medicover AB (publ), Annual General Meeting, Apr 27, 2023

Second quarter 2022 earnings released

Independent Chairman recently bought kr2.8m worth of stock

Medicover AB (publ) (OM:MCOV B) acquired Konzilijum.

Investor sentiment deteriorated over the past week

Medicover AB (publ) (OM:MCOV B) signed an agreement to acquire Übag Mvz Meindentist Gbr.

High number of new directors

Medicover AB (publ) (OM:MCOV B) acquired Kliniki Terapii Allenort Holding Sp. z o.o.

Independent Chairman recently bought kr3.3m worth of stock

Medicover AB (Publ) Elects Anne Berner and Azita Shariati as Board Members

Full year 2021 earnings released: EPS: €0.69 (vs €0.18 in FY 2020)

Insufficient new directors

Upcoming dividend of €0.12 per share

Full year 2021 earnings released: EPS: €0.69 (vs €0.18 in FY 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

General Legal Counsel recently bought kr518k worth of stock

Now 24% undervalued after recent price drop

Medicover AB (publ) Proposes Dividend for the Financial Year 2021, Expected Payable on 6 May 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Medicover AB (publ) (OM:MCOV B) acquired an unknown majority stake in Mediplus Clinic.

Investor sentiment deteriorated over the past week

Chief Financial Officer recently sold kr1.4m worth of stock